01740nam a22004697a 4500
200103s20202020 xxu||||| |||| 00| 0 eng d
1744-6872
10.1097/FPC.0000000000000392 [doi]
Ovid MEDLINE(R)
31851125
PharmGKB summary: sertraline pathway, pharmacokinetics.
Pharmacogenetics and Genomics. 30(2):26-33, 2020 02.
Pharmacogenet Genomics. 30(2):26-33, 2020 02.
Pharmacogenet Genomics. 2019 Dec 14
Pharmacogenetics and genomics
2020
FY2020
aheadofprint
ppublish
2020-01-03
Pharmacogenetics and Genomics. 2019 Dec 14
Available online through MWHC library: 2005 - present
English
*Mental Disorders/dt [Drug Therapy]
*Serotonin Uptake Inhibitors/pk [Pharmacokinetics]
*Sertraline/pk [Pharmacokinetics]
Drug Interactions
Humans
Pharmacogenomic Variants
Serotonin Uptake Inhibitors/ae [Adverse Effects]
Serotonin Uptake Inhibitors/pd [Pharmacology]
Sertraline/ae [Adverse Effects]
Sertraline/pd [Pharmacology]
Signal Transduction/de [Drug Effects]
MedStar Health
Pharmacogenomics
Journal Article
Smith, D Max
Altman RB, Bobonis Babilonia M, Hicks JK, Huddart R, Klein TE, Ramsey LB, Smith DM, Strawn JR
https://dx.doi.org/10.1097/FPC.0000000000000392
https://dx.doi.org/10.1097/FPC.0000000000000392
ART
Article
0
0
0
0
Article
authcat
authcat
2020-01-03
0
31851125
31851125
2020-01-03
2020-01-03
ART
4842
4842